Calithera Biosciences Past Earnings Performance
Past criteria checks 0/6
Key information
81.5%
Earnings growth rate
85.3%
EPS growth rate
| Biotechs Industry Growth | 17.0% |
| Revenue growth rate | -100.0% |
| Return on equity | -194.4% |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
Recent updates
Calithera gains 16% as FDA awards Fast Track status for lung cancer candidate
Oct 03Calithera rises 8% after HC Wainwright upgrades rating to buy
Aug 29Is Calithera Biosciences (NASDAQ:CALA) In A Good Position To Invest In Growth?
Aug 17
We Think Calithera Biosciences (NASDAQ:CALA) Needs To Drive Business Growth Carefully
Dec 17We Think Calithera Biosciences (NASDAQ:CALA) Needs To Drive Business Growth Carefully
Aug 27The Upcoming Calithera Cystic Fibrosis Data Could Be Significant
Aug 03Calithera Biosciences Investor Presentation - Slideshow
May 08Is Calithera Biosciences (NASDAQ:CALA) In A Good Position To Deliver On Growth Plans?
May 02What Kind Of Investors Own Most Of Calithera Biosciences, Inc. (NASDAQ:CALA)?
Mar 10Calithera Biosciences, Inc. (NASDAQ:CALA) Shares Could Be 46% Below Their Intrinsic Value Estimate
Jan 17Calithera sinks as telaglenastat fails in kidney cancer study; lowers headcount
Jan 04Companies Like Calithera Biosciences (NASDAQ:CALA) Are In A Position To Invest In Growth
Dec 13Calithera Biosciences Poised For Long-Term Success
Nov 25Calithera Biosciences (CALA) Investor Presentation - Slideshow
Nov 06Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Calithera Biosciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 0 | -21 | 14 | 0 |
| 30 Sep 22 | 0 | -84 | 15 | 51 |
| 30 Jun 22 | 7 | -85 | 19 | 51 |
| 31 Mar 22 | 10 | -107 | 19 | 51 |
| 31 Dec 21 | 10 | -115 | 21 | 51 |
| 30 Sep 21 | 10 | -68 | 22 | 0 |
| 30 Jun 21 | 3 | -80 | 20 | 0 |
| 31 Mar 21 | 0 | -86 | 21 | 0 |
| 31 Dec 20 | 0 | -90 | 20 | 0 |
| 30 Sep 20 | 0 | -89 | 19 | 0 |
| 30 Jun 20 | 0 | -87 | 18 | 0 |
| 31 Mar 20 | 0 | -91 | 17 | 0 |
| 31 Dec 19 | 0 | -90 | 17 | 0 |
| 30 Sep 19 | 0 | -88 | 15 | 0 |
| 30 Jun 19 | 0 | -86 | 14 | 0 |
| 31 Mar 19 | 17 | -65 | 14 | 0 |
| 31 Dec 18 | 22 | -55 | 13 | 0 |
| 30 Sep 18 | 30 | -46 | 13 | 0 |
| 30 Jun 18 | 37 | -33 | 13 | 0 |
| 31 Mar 18 | 27 | -35 | 13 | 0 |
| 31 Dec 17 | 26 | -28 | 13 | 0 |
| 30 Sep 17 | 19 | -26 | 12 | 0 |
| 30 Jun 17 | 11 | -29 | 11 | 0 |
| 31 Mar 17 | 4 | -34 | 11 | 0 |
| 31 Dec 16 | 0 | -38 | 11 | 0 |
| 30 Sep 16 | 0 | -37 | 10 | 6 |
| 30 Jun 16 | 0 | -37 | 10 | 13 |
| 31 Mar 16 | 0 | -34 | 9 | 18 |
| 31 Dec 15 | 0 | -33 | 9 | 0 |
| 30 Sep 15 | 0 | -31 | 9 | 23 |
| 30 Jun 15 | 0 | -28 | 8 | 20 |
| 31 Mar 15 | 0 | -25 | 7 | 19 |
| 31 Dec 14 | 0 | -22 | 5 | 16 |
| 30 Sep 14 | 0 | -19 | 4 | 14 |
| 30 Jun 14 | 0 | -17 | 4 | 13 |
| 31 Mar 14 | 0 | -14 | 3 | 11 |
Quality Earnings: CALA is currently unprofitable.
Growing Profit Margin: CALA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if CALA's year-on-year earnings growth rate was positive over the past 5 years.